{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-071446","form_type":"8-K","ticker":"REGN","cik":"0000872589","company_name":"REGENERON PHARMACEUTICALS, INC.","filed_at":"2022-06-15T23:59:59+00:00","discovered_at":"2026-05-14T18:04:04.038930+00:00","generated_at":"2026-06-25T01:47:02.658687+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Regeneron shareholders re-elect four Class I directors, approve auditor, advisory pay vote at 2022 annual meeting","bullets":["Board nominees Bassler, Brown, Schleifer, Yancopoulos re-elected with 96.9M, 86.3M, 110.1M, 109.5M votes for, respectively.","Ratification of PwC as independent auditor for FY2022 approved: 111.8M for, 4.5M against.","Advisory vote on named executive officer compensation approved: 97.8M for, 13.6M against, 4.7M broker non-votes.","All three proposals passed; no contested items or shareholder proposals on ballot."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-071446","json":"https://secwatch.observer/filing/0001104659-22-071446.json","markdown":"https://secwatch.observer/filing/0001104659-22-071446.md","text":"https://secwatch.observer/filing/0001104659-22-071446.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/872589/000110465922071446/0001104659-22-071446-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/872589/000110465922071446/tm2218439d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T01:47:02.658687+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}